Alvotech (ALVO) Interest Coverage Ratio Growth (1y) (2022 - 2026)
Powered by 
Analysis
Alvotech (ALVO) Interest Coverage Ratio Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.58 Bn | 38.93 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -97.39% |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | -85.68% |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.34 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 526.37 Mn | 2.10 Bn | 95.71% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -649.91% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn | -11.17% |
| 9 | Fennec Pharmaceuticals | 408.84 Mn | 367.59 Mn | 17.15 Mn | 12,688.80% |
| 10 | RedHill Biopharma | 180.35 Mn | 180.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 649.91% |
| Mar 31, 2026 | 89.83% |
| Dec 31, 2025 | -262.21% |
| Sep 30, 2025 | -70.63% |
| Jun 30, 2025 | -84.46% |
| Mar 31, 2025 | -986.10% |
| Dec 31, 2024 | -52.37% |
| Jun 30, 2024 | 48.07% |
| Mar 31, 2024 | -80.20% |
| Dec 31, 2023 | -27.76% |
| Aug 31, 2023 | -24.30% |
| Jun 30, 2023 | 74.89% |
| Mar 20, 2023 | -27.76% |
| Dec 31, 2022 | -8.35% |